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The life of an mRNA from transcription to degradation oﬀers multiple control check points that regulate gene expression.
Transcription, splicing, and translation have been widely studied for many years; however, in recent years, new layers of
posttranscriptional and posttranslational control have been uncovered. They involve the regulation of the metabolism of mRNA
in cytoplasmic foci. They are collections of ribonucleoprotein complexes that, in most cases, remain still uncharacterized, except
the processing bodies (PBs) and stress granules (SGs), which have been studied (and reviewed) in detail. A challenging prospective
is to know how many diﬀerent classes of foci exist, which functions they support, how are they formed, and how do they relate one
to each other. Here, we present an update of the component of the diﬀerent granules, a possible function, and hypothesis on their
in vivo dynamics related to translational control.
1.Introduction
Inrecentyears,severalcytoplasmicfoci/granulesthatcontain
proteins and RNA have been described. Two of them have
been studied in more detail as they are related to mRNA
silencing: stress granules (SG) and processing bodies (PB).
SG are repressed mRNPs transiently induced in response
to cellular stress. They range from 0,5 to 5μm[ 1]. PB
are discrete RNP cytoplasmic foci of 0,1-2μm where the
machinery of RNA interference, degradation and storage
locates. In PB the mRNAs are forming mRNP complexes
either repressing translation, in degradation complexes or
stored for further use [2, 3] .S Ga n dP Bh a v eb e e ns h o w nt o
share a growing number of proteins that are added in a day-
to-day basis to the list of their components. SG, PB and other
cytoplasmic foci are highly dynamic structures, although PB
are quite stable over the time [4]; see also Supplementary
Movie 1 available online at doi:10.1155/2012/504292. They
are in a dynamic steady state with other mRNPs, such as
polysomes in response to the translational state of the cell
[5]. Although we do not intend to extensively review SG and
PB, which have been matter of ﬁne reviews in the last years
[6–10], we will overview their functions before we address
neglected issues and hypothesis.
2. Stress Granules
Translation initiation is the key regulatory step of trans-
lational control. Therefore, it is the most sensitive step to
changes in the cellular environment, including stress. A key
step in translation initiation inhibition is the phosphoryla-
tion of eIF2α, which results in an increase on the aﬃnity of
eIF2-GDP for eIF2B, sequestering this factor to prevent new
round of translational initiation [11]. During this process,
translation is inhibited and polysomes become released from
the mRNA leading to the accumulation of inactive mRNPs
in SG. The SG are in equilibrium with active polysomes.
Proteinelongationinhibitors,suchascycloheximide,prevent
the assembly of SG by blocking the polysomes in an
inactive state, while protein initiation inhibitors promote the
formation of SG [8]. Table 1 shows the components of SG
described up to now. They can be classiﬁed in three main
groups as follows.2 Comparative and Functional Genomics
Table 1: Components of stress granules.
Protein Function Interacting proteins
Ago2 Cleaves interfered RNA RISC, FXR1
APOBEC3G Antiviral response ?
Ataxin-2 Translation PABP-1
Caprin-1 Cell growth G3BP
CPEB mRNA repression RCK, eIF4E, FXR1
DIS1 Unknown eIF3h
eIF3 Translation 40S, eIF4G
eIF4E Translation CPEB, Smaug, eIF4G, 4ET
eIF4G Translation eIF4E, eIF3, PABP-1
FAST Translation TIA-1
FMRP, FXR1 Translation Ago2, RISC
FBP, KSRP mRNA degradation TIA-1
FUS/TLS Transcriptional control Transcriptional machinery
G3BP Ras signalling Caprin
HuR mRNA stabilization ?
IP5K Signalling ?
Lin28 Developmental control ?
LINE 1 ORF1p Transposon ?
MLN51 Splicing Exon junction
PABP-1 Translation eIF4G, eIF3, ataxina-2
RCK(p54) mRNA degradation GE-1, TTP
Plakophilin Adhesion G3BP, FXR1
PMR1 mRNA degradation TIA-1
Pumilio 2 mRNA silencing ?
Rap 55 mRNA silencing ?
Rpb4 Transcription ?
SRC3 Transcription TIA-1
Staufen mRNA silencing ?
SMN RNP assembly Complejo SMN
TDP-43 Transcription and splicing regulator eIF4G, eIF3, eIF2, ribosomal proteins, STAU-1, Xnr
TIA-1(rox-8), TIAR mRNA silencing FAST, SRC3, PMR1, FBP
TRAF2 Signalling eIF4G
TTP, BRF-1 mRNA silencing RCK (p54)
YB-1 Cold shock ?
ZBP1 Localization ?
(1) Core components: stalled initiation complexes (pol-
yadenylated mRNAs and translation factors eIF4E, eIF4A,
eIF4G, eIF3, eIF2, PABP, and proteins of the small ribosome
subunit).
(2) RNA-binding proteins associated to silencing and
transcript stability: TIA-1, TIAR [12], FAST, Argonaute [13],
CPEB, smaug, DExD/H-box RCK/p54 (o Dhh1), XRN1 [5].
(3) RNA-binding proteins associated to mRNA metabo-
lism either translation of degradation such as G3BP [14]a n d
Staufen [15].
The key concept regarding SG is that they are responsible
of protecting the mRNA during cell stress, altering the com-
position of the mRNPs in a reversible manner. As soon as the
cell recovers, the mRNPs regain their translational capacity.
3.ProcessingBodies
These structures have been described many times since 1997,
when Bashkirov et al. observed that the exonuclease Xrn1
is located in small granular structures in the cytoplasm of
mammalian cells and call them “Xrn1 foci” [17]. Later on,
the decapping enzyme Dcp2 was also described to occur in
cytoplasmic foci [18]. Contemporary, Eystathioy et al. have
described that a protein associated to neuropathy named
GW182 occurs in cytoplasmic speckles called GW bodies
[19, 20]. Other RNA-related protein, the eIF4E-transporter,
was also localized in discrete cytoplasmic foci [16, 21, 22].
Short after, a seminal work of Sheth and Parker established
the functional bases of the now called PB that resulted in
the same structures described many times before [23]. TheyComparative and Functional Genomics 3
Table 2: Components of processing bodies.
Protein Function Organisms
XRN1, Sc Kem1 5  → 3  exonuclease Human, mice, Sc
GW182, Ce AIN-1 miARN function Human, Dm, Ce
DCP2, Ce DCAP2 Decapping Human, Dm, Ce, Sc
DCP1, Ce DCAP1 Decapping Human, Dm, Ce, Sc
Hedls, Ge-1 Decapping coactivator Human, Dm
Dm CG5208, Pat1 Decapping coactivator Dm, Sc
EDC3 (Lsm16) Decapping coactivator Human, Dm, Sc
Lsm1-7 Decapping coactivator Human, Sc
RAP55 Putative decapping coactivator Human
RCK/p54, Dm Me31B, Ce CGH-1, Sc Dhh1 Decapping coactivator, translational control Human, Dm, Ce, Sc
eIF4E Translation initiation Human, rat, mouse, Dm, Sc
eIF4E-T Translational repression Human
SMG7 Nonsense mediated decay Human
SNG5 Nonsense mediated decay Human
UPF1, Sc Nam7 Nonsense mediated decay Human, Sc
UPF2 Nonsense mediated decay Human
UPF3 Nonsense mediated decay Human
Argonaute siRNA/miRNA pathways Human, Dm, Ce
CCR4-CAF1-NOT complex Deadenylation Human, Dm, Sc
CPEB Translational control Human
FAST S/T phosphoprotein activator of Fas Human
TTP ARE-mediated mRNA degradation Human
Staufen mRNA localization Human, mice, Dm
Rbp1 Mitochondrial RNA degradation Sc
Rbp4 RNA pol II subunit Sc
Sbp1 Suppressor of deccaping Sc
Germin 5 Part of small nuclear RNPs Human
Dcs2 Stress-induced regulator Sc
APOBEC3G, APOBEC3F Antiviral activity Human
demonstrated that PB contains enzymes involved in the
degradation of the mRNA. Later one further studies showed
that they are also related to miRNA metabolism and can
store mRNAs to bring them back to polysomes (reviewed in
[3, 24]. They include, diﬀerent than SG, neither ribosomal
proteins nor translation factors, except eIF4E. They do not
present either the exosome components [25]. eIF4G and
PABP were found in yeast PB, although at low level and
in stress conditions resulting on glucose deprivation [26].
Proteins and mRNA can reversely go in and out of PB [25].
TherelationshipofPBandpolysomesisdemonstratedbythe
blocking of PB formation by cycloheximide. A summary of
the components in diﬀerent organisms is shown in Table 2.
The occurrence of such large and diverse set of proteins (and
thelistcontinuouslygrowsup)suggeststhatPBsareinvolved
in a plethora of posttranslational processes regulating gene
expression,suchasmRNAdegradationandsilencing.mRNA
degradation starts with the shortening of the poly-A tail—
the deadenylation. In eukaryotes, there are several complexes
involved in the process: PARN2-PARN3 initiates the pro-
cess, which continues with the action of the CAF1-CCR4-
NOT complex. Later on, mRNA degradation continues by
nucleolytic cleavage on both ends. 3  → 5  degradation is
catalyzed by the exosome and the SKI complex, while 5  →
3  degradationrequirespreviousdecappingbyDCP2andthe
coactivator DCP1 and the action of the exonuclease XRN1.
All these enzyme localize in PB. There are several evidences
indicating that mRNA degradation occurs in PB.
(i) The assembly of PB depends on mRNA, as RNase
treatmentofthecellsinducesthedisappearingofPB[27,28].
(ii) Inhibition or removal of the deadenylase Ccr4
reduces the number and size of PB, while the removal of the
downstream-acting enzymes Xrn1 and Dcp1 does not aﬀect
the stability of PB [21].
(iii) mRNA degradation intermediates are present in PB
[23].
Therefore, one can conclude that mRNA degradation
occurs in PB and depends on the existence of degradation
enzymes and mRNA degradation intermediates [21, 23, 25,
29]. Many of the PB components are not restricted to the
foci and also are present in the soluble cytoplasm and nuclei,
suggesting that the diﬀerent processes might start before
the mRNAs entry into PB. PBs are also related to mRNA
quality control mechanisms, such as nonsense-mediated4 Comparative and Functional Genomics
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Figure 1: Colocalization of eIF4E with components of PBs and SGs shows a diversity of cytoplasmic foci quality. The experiment shows that,
in every case, the granules contain both components or either one or the other in diﬀerent quantities. This would represent intermediates or
diﬀerent forms of eIF4E-containing foci. Drosophila melanogaster S2 cells were transfected with proteins fusion CFP-Lsm-1 or CFP-Me31B.
GW182, eIF4E, and Rox8 (the TIA-1 ortholog in Drosophila) were revealed using antibodies against GW182, anti-V5, and anti-TIA-1,
respectively. In the bottom panel (row 4), the cells were prestressed with arsenite for 30 minutes.
decay (NMD). The detection of premature termination in
the cells by spotting an mRNA with an abnormal stop
codon is mediated by a surveillance complex composed by
UPF1, UPF2 y UPF3, additional proteins, namely, SMG1,
and SMG5-7 [30–32]. As soon as the surveillance complex
is assembled, the degradation enzymes (Dcp1, Xrn1) are
recruited to the mRNA in PB. Although the degrading
enzymes are located in PB, the mechanism of recruitment is
unknown. In silencing, there are two types of small mRNAs
that regulate posttranscriptional gene expression: siRNAs
and miRNAs. Despite the diﬀerent mechanism of silencing,
in both cases participate the protein Argonaute (Ago) and
the RISC (RNA-induced silencing complex). In the case of
siRNAs, Ago produces an endonucleolytic cleavage of the
mRNA to promote degradation by the 3  → 5  and 5  →
3  decay machinery in PB. In the case of the miRNAs, theyComparative and Functional Genomics 5
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Figure 2: Relationship among active polysomes and PBs. The recruitment of active polysomes to PB implies the removal from the mRNA
of the translation factors by translational repressors. Some of them have been demonstrated to interact with eIF4E in vivo (rck/p54 and
eIF4E-T, [16]). They further interact and/or recruit the enhancers of decapping Lsm1-7 or the miRNA-related protein GW182 to form the
PB. Later on, they assemble the decapping and degradation enzymes and/or the proteins required for silencing and storage into PB. All the
intermediate steps of this process can represent diﬀerent populations of granules coexisting in the cell and visible with diﬀerent morphology
that might reﬂect a variety of components and/or diverse stoichiometry.
recruit Ago to direct the repressed mRNA to degradation
mediated by the PB proteins GW182, CCR4-CAF1-NOT1,
DCP2, DCP1, and XRN1.
4. The Cycle of an mRNA in the Cell: SG, PB,
Polysomes, and the Unknown Intermediates
From the previous analysis, one can establish many unsolved
aspects on cytoplasmic foci function. One of them is the
dynamic of the mRNP remodeling. The current model
suggests an active movement of mRNPs from and to
polysomes and from and to SG and PB [33]. However, how
does it happen and the factors involved are not known.
Translationally active mRNAs can interact, in response to
errors in translational initiation or to speciﬁc recruitment
of regulatory proteins, with translational repressors such as
Dhh1, Pat 1, Lsm1-7, eIF4E-T. Those factors would promote
the replacement of the translational machinery from the
mRNA,promotethecapremovalanddeterminedegradation
[33] or the accumulation of silenced mRNA in PB. Within
PB, mRNPs could undergo further remodeling and deﬁne
a path to follow, including their return to polysomes. In
addition, PBs have been shown to interact and exchange
components ortheir ownnature withSG (reviewedin[6,7])
in a process that may result in mRNPs intermediates of
unknown nature. Evidence for the diversity of cytoplasmic
foci and their components results from immunocytochem-
istry and colocalization studies. A common factor present in
most cytoplasmic mRNPs is the cap-binding protein eIF4E.
eIF4E occurs in active polysomes as a translation initiation
factor, in SG as part of the stalled initiation complex,
and in PB as the only translation factor present there in
multicellular eukaryotes. We observed in Drosophila S2 cells
that eIF4E colocalizes with diﬀerent pairs of markers, either
for PB (GW182, Lsm1, Me31B—an ortholog of the helicase
rck/p54) or SG (TIA-1) and that the colocalization does
not occur in all foci in the same way (PVF, CL, and RRP,
unpublished data and Figure 1). In some cases, the foci
contain one, the other, or both components. In the foci that
show colocalization of both factors, the relative amount of
each component may vary from foci to foci, as judged by
confocal microscopy quantiﬁcation of the colocalized factors
(PVF, CL, RRP, unpublished observation). This implies that
there are a diversity of granules. An appealing hypothesis
is that eIF4E is a common link among diﬀerent mRNPs,
playing diﬀerent roles depending on their interactors. One
plausible function could be that the accumulation of mRNPs
in eIF4E-containing foci is a way to regulate the rate of
translation in diﬀerent physiological states (cell cycle phases,
developmental stages, circadian rhythms). Moreover, it has
been reported that, in mammalian cells, eIF4E interacts in
PB with at least two factors, rck/p54 and eIF4E-T [21].
These are simultaneous interactions within the PB and imply
that both proteins could contact diﬀerent domains of the
same eIF4E molecule or that they would represent diﬀerent
populationsofmRNPsordiﬀerentfunctionswithinthesame
PB. In either cases, the complexity of the interactions in
vivo is more diverse than it has been expected. A model for
the remodeling of active mRNPs to silence and degradation
basedonAndreietal.[21]isdepictedinFigure 2.Thismight
requireseveralintermediatestatesthatcanbethematuration
steps of a mRNA in the way of a PB or within a PB. This6 Comparative and Functional Genomics
would correlate with the large diversity of components and
interactions within a cytoplasmic foci and the diversity of
the foci within a cell. The understanding of the dynamics
of mRNP is far from clear and unpredictable paths remain
to be discovered. They will need further research and more
sophisticated methods for in vivo studies.
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